NIH-funded research NIH-funded research

Investigating how cell signaling affects the development and function of insulin-producing cells in the pancreas

Official title: Cell signaling and transcription factors in pancreatic islet development and function

Funded at University of Michigan at Ann Arbor · NIH-11058414 · Data updated 2026-11-12

This study is exploring how certain signals and factors help create insulin-producing cells in the pancreas, with the goal of improving treatments for diabetes by making better replacement cells from human stem cells.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startApril 6, 2023
Project endMarch 31, 2026
Funding year2025
Award (this year)$248,999
NIH project number5R00DK128537-05
Project IDNIH-11058414 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with type 1 or type 2 diabetes who may benefit from advancements in beta cell replacement therapies.

Less likely to help

Patients who do not have diabetes or those whose diabetes is well-managed without the need for islet replacement therapy may not receive benefit from this research.

What this research studies

This research focuses on understanding the mechanisms behind pancreatic islet development and function, particularly how cell signaling and transcription factors influence the formation of insulin-producing beta cells. By using in vivo models, the study aims to refine protocols for generating these cells from human pluripotent stem cells, which could lead to improved islet replacement therapies for diabetes. The research builds on existing knowledge from mouse studies to enhance the efficiency of producing mature beta cells for potential transplantation. Patients may benefit from advancements in diabetes treatment through better access to effective therapies.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for diabetes by improving islet replacement therapy.

How similar studies have gone: Previous research has shown promise in using similar approaches to enhance beta cell production, but this specific methodology is still being refined.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Lorberbaum, David — University of Michigan at Ann Arbor
  • Study coordinator: Lorberbaum, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.